GlassScriptPhysician profile
Mark S Campbell
NPI 1770571432
$619.19
in general payments reported to CMS, 2019-2025
14 companies · $72.41 in 2025
The $72.41 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $26.11 · 2021: $37.18 · 2022: $14.86 · 2023: $48.34 · 2024: $207 · 2025: $72.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $328.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $112.50 | 2023-2025 | Breztri, Farxiga, Airsupra |
| Amgen INC. | $105.87 | 2019-2025 | Prolia, Evenity |
| Lilly USA, LLC | $66.18 | 2019-2024 | Mounjaro, Zepbound |
| Novartis Pharmaceuticals Corporation | $63.86 | 2024 | |
| Merck Sharp & Dohme LLC | $48.83 | 2019-2024 | Gardasil, Gardasil 9, Capvaxive |
| Novo Nordisk INC | $48.18 | 2019-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $37.14 | 2019 | |
| Intuitive Surgical, INC. | $31.55 | 2019 | |
| Abbvie INC. | $22.75 | 2024 | |
| Boston Scientific Corporation | $21.86 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.13 | 2019 | |
| Sanofi-Aventis U.S. LLC | $15.91 | 2019 | |
| Ethicon US, LLC | $14.40 | 2019 | |
| Pfizer INC. | $14.03 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.